1. Home
  2. XOMAP vs SIGIP Comparison

XOMAP vs SIGIP Comparison

Compare XOMAP & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMAP

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

N/A

Current Price

$26.87

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

SIGIP

Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

N/A

Current Price

$16.70

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XOMAP
SIGIP
Founded
N/A
N/A
Country
United States
United States
Employees
13
2800
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOMAP
SIGIP
Price
$26.87
$16.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
XOMAP
SIGIP
Relative Strength Index (RSI) 58.46 44.32
Support Level $26.57 $16.67
Resistance Level $27.10 $16.86
Average True Range (ATR) 0.23 0.17
MACD 0.01 0.03
Stochastic Oscillator 75.52 35.01

Price Performance

Historical Comparison
XOMAP
SIGIP

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.

Share on Social Networks: